Literature DB >> 26358860

Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up.

Chiara Arrizza1,2, Andrea De Gottardi3, Ezio Foglia4, Matthias Baumgartner5,6, Matthias Gautschi1,2, Jean-Marc Nuoffer1,2.   

Abstract

Cardiomyopathy is a frequent complication in propionic acidemia. It is mostly rapidly fatal and independent of the metabolic control or medical intervention. Here, we present the reversal of a severe cardiomyopathy after liver transplantation in a patient with propionic acidemia and the long-term stability after ten years. Liver transplantation in patients with propionic acidemia may be considered a valid and long-lasting treatment when cardiomyopathy is progressive and unresponsive to medical therapy.
© 2015 Steunstichting ESOT.

Entities:  

Keywords:  cardiomyopathy; metabolic decompensation; orthotopic liver transplantation; propionic acidemia

Mesh:

Year:  2015        PMID: 26358860     DOI: 10.1111/tri.12677

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

Review 1.  Propionyl-CoA carboxylase - A review.

Authors:  Parith Wongkittichote; Nicholas Ah Mew; Kimberly A Chapman
Journal:  Mol Genet Metab       Date:  2017-10-07       Impact factor: 4.797

2.  Successful heart transplantation in a patient with adolescent-onset dilated cardiomyopathy secondary to propionic acidaemia: a case report.

Authors:  Osamu Seguchi; Koichi Toda; Yusuke Hamada; Tomoyuki Fujita; Norihide Fukushima
Journal:  Eur Heart J Case Rep       Date:  2022-05-13

Review 3.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

Review 4.  Organic acidurias in adults: late complications and management.

Authors:  Ali Tunç Tuncel; Nikolas Boy; Marina A Morath; Friederike Hörster; Ulrike Mütze; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2018-01-15       Impact factor: 4.982

Review 5.  Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.

Authors:  Nishitha R Pillai; Bridget M Stroup; Anna Poliner; Linda Rossetti; Brandy Rawls; Brian J Shayota; Claudia Soler-Alfonso; Hari Priya Tunuguntala; John Goss; William Craigen; Fernando Scaglia; V Reid Sutton; Ryan Wallace Himes; Lindsay C Burrage
Journal:  Mol Genet Metab       Date:  2019-11-07       Impact factor: 4.797

6.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

7.  Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups.

Authors:  Tzu-Hung Chu; Yin-Hsiu Chien; Hsiang-Yu Lin; Hsuan-Chieh Liao; Huey-Jane Ho; Chih-Jou Lai; Chuan-Chi Chiang; Niang-Cheng Lin; Chia-Feng Yang; Wuh-Liang Hwu; Ni-Chung Lee; Shuan-Pei Lin; Chin-Su Liu; Rey-Heng Hu; Ming-Chih Ho; Dau-Ming Niu
Journal:  Orphanet J Rare Dis       Date:  2019-04-02       Impact factor: 4.123

Review 8.  Post-transplantation Outcomes in Patients with PA or MMA: A Review of the Literature.

Authors:  Sufin Yap; Roshni Vara; Ana Morais
Journal:  Adv Ther       Date:  2020-04-08       Impact factor: 3.845

9.  Therapeutic potential of living donor liver transplantation from heterozygous carrier donors in children with propionic acidemia.

Authors:  Zhi-Gui Zeng; Guang-Peng Zhou; Lin Wei; Wei Qu; Ying Liu; Yu-Le Tan; Jun Wang; Li-Ying Sun; Zhi-Jun Zhu
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.